Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 26787
Evènement :3rd Microbiome Drug Development Boston Summit

Dates :Mardi 19 Juin 2018 - Vendredi 22 Juin 2018

Lieu :Seaport Hotel and World Trade Centre
1 Seaport Lane
02210 Boston, Massachusetts, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--




As the knowledge of the microbiome continues to deepen, fundamental understanding of mechanism of action and demonstrating causality continue to improve. As such, the Microbiome Movement has become more committed than ever to work alongside innovative researchers and industry leaders to build events that focus on applied science and translate cutting edge microbiome R&D into safe, effective and commercially successful products across a number of industry-specific verticals.
Positioned at the heart of pharmaceutical, agricultural, nutritional and animal health R&D, the Microbiome Movement continues to help accelerate the discovery, development and delivery of breakthrough solutions to global challenges to benefit human health. For each specific industry where the microbiome will have a real impact, we’re building an exclusive community for you to maximize the opportunity.
The Microbiome Drug Development Summit continues to be the industry leading forum that focuses exclusively on the development and commercialization of microbiome-based therapeutics; with case-studies from target discovery all the way through to clinical trial development, manufacturing and beyond. We will once again unite KOL’s, senior drug developers, microbiome-technology experts and breakthrough researchers to translate the human microbiome into simply effective medicines.
Early booking and group discounts are available for this event. Bring your team to cover all bases and maximize your learning opportunity through our tracked sessions. Email info@hansonwade.com to enquire about discounts.
Website https://go.evvnt.com/206448-0?pid=4319
Brochure https://go.evvnt.com/206448-1?pid=4319
Booking https://go.evvnt.com/206448-2?pid=4319
Conference Only - Register by March 23: USD 2199
Conference Only - Standard Rate: USD 2799
Speakers: Cathryn Nagler (ClostraBio), Christophe Bonny (Enterome Bioscience), Mark Smith (Finch Group Therapeutics), Anuk Das (Janssen Human Microbiome Institute), Jean Luc-Treillou (LNC Therapeutics), Trevor Lawley (Microbiotica), Ken Blount (Rebiotix), Daniel Couto (Vedanta Biosciences), Jessica Schneider (Takeda) & Many More
Time: on Tuesday June 19, 2018 at 8:00 am (ends Friday June 22, 2018 at 5:00 pm)


Plan et itinéraire
Adresse de la conférence :
Seaport Hotel and World Trade Centre
1 Seaport Lane
02210 Boston
Massachusetts, États-Unis
Plan et itinéraire


Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama


3rd Microbiome Drug Development Boston Summit Pharmacie
microbiome, microbiome drug development, microbiome drug development summit, microbiome drug development boston, microbiome movement, microbiome therapeutics, microbiome-based therapeutics, microbiome therapy
Tout public
-- -- --


Pour plus d'informations sur 3rd Microbiome Drug Development Boston Summit, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama

Recommander cet évènement